High-throughput screening has enabled the identification, development, and FDA approval of drugs for one genetic ion channel disorder, cystic fibrosis, which is caused by impaired intracellular transport (trafficking) of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride ion channel to the cell membrane (10). Here, CFTR is linked to cystic fibrosis.